Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors
========================================================================================================================================================

* Xiaozhen Zhang
* Mengyi Lao
* Jian Xu
* Yi Duan
* Hanshen Yang
* Muchun Li
* Honggang Ying
* Lihong He
* Kang Sun
* Chengxiang Guo
* Wen Chen
* Haitao Jiang
* Xiaoyu Zhang
* Xueli Bai
* Tingbo Liang